ArticleJournal of hepatology2013

Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling.

Harel Dahari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.